TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT07245836

Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Disease and Associated Ocular Surface Inflammation

Cause of deathOther Automatic label, confidence 0.5, unverified. How labels are made.
“This study was not halted prematurely. This record represents a duplicate entry and has therefore been withdrawn. The correct and complete study information can be found under identifier NCT07007702.”

The sponsor’s own words in the registry.

Life of this trial

202520262027Started2025-01-20Primary completion2025-06-03Stopped2025-07-06Registered2025-09-22

Vital statistics

Status
Terminated
Phase
Phase 4
Sponsor
Medical University of Vienna
Sponsor type
University, hospital or other
Conditions
Dry Eye Disease (DED)
Interventions
Thealoz Total® Eye Drops, Laboratoires Thea, Clermont Ferrand, France
Participants
30
Sites
1
Countries
Austria

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.